Dr. Sanjiv Jain, MD

Claim this profile

Carle Foundation Hospital

Studies Stroke
1 reported clinical trial
1 drug studied

Affiliated Hospitals

Image of trial facility.
Carle Foundation Hospital

Clinical Trials Sanjiv Jain, MD is currently running

Image of trial facility.

tDCS

for Post-Stroke Motor Impairment

Significant motor impairments occur in 80% of individuals after moderate to severe stroke and impact the body side to the lesioned hemisphere. Typical motor impairments involve loss of dexterity with highly prevalent upper limb flexion synergy. Advances in treating flexion synergy impairments have been hampered by a lack of precision rehabilitation. Previous studies suggest and support the role of cortico-reticulospinal tract (CRST) hyperexcitability in post-stroke flexion synergy. CRST hyperexcitability is often caused by damage to the corticospinal tract (CST). We hypothesize that: 1) inhibiting the contralesional dorsal premotor cortex (cPMd) will directly reduce the CRST hyperexcitability and thus, reduce the expression of the flexion synergy; 2) facilitating the ipsilesional primary motor cortex (iM1) will improve the excitability of the damaged CST, therefore reducing the CRST hyperexcitability and the flexion synergy. we propose to use a novel targeted high-definition tDCS (THD-tDCS) to specifically modulate the targeted cortical regions for testing his hypothesis, via the following aims: Aim 1. Evaluate the effect of cathodal THD-tDCS over the cPMd on reducing the CRST hyperexcitability and the expression of flexion synergy. Aim 2. Evaluate the effect of anodal THD-tDCS over the iM1 on improving the excitability of the CST, and determine whether this, thus, also reduces the CRST hyperexcitability and the flexion synergy. Aim 3. Evaluate the confluence effect of bilateral THD-tDCS, i.e., simultaneous cathodal stimulation over the cPMd and anodal over the iM1.
Recruiting0 awards N/A2 criteria

More about Sanjiv Jain, MD

Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Sanjiv Jain, MD has experience with
  • Transcranial Direct Current Stimulation (high- Definition)
Breakdown of trials Sanjiv Jain, MD has run

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sanjiv Jain, MD specialize in?
Sanjiv Jain, MD focuses on Stroke and other conditions. In particular, much of their work with Stroke has involved treating patients, or patients who are undergoing treatment.
Is Sanjiv Jain, MD currently recruiting for clinical trials?
Yes, Sanjiv Jain, MD is currently recruiting for 1 clinical trial in Urbana Illinois. If you're interested in participating, you should apply.
Are there any treatments that Sanjiv Jain, MD has studied deeply?
Yes, Sanjiv Jain, MD has studied treatments such as Transcranial direct current stimulation (high- definition).
What is the best way to schedule an appointment with Sanjiv Jain, MD?
Apply for one of the trials that Sanjiv Jain, MD is conducting.
What is the office address of Sanjiv Jain, MD?
The office of Sanjiv Jain, MD is located at: Carle Foundation Hospital, Urbana, Illinois 61801 United States. This is the address for their practice at the Carle Foundation Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security